@article{417f452360f8482e8645feddf3b97db6,
title = "Pregnancy A {"}modifiable{"} risk factor in MS?",
author = "Martin Daumer and Weinshenker, \{Brian G.\} and Rhonda Voskuhl",
note = "Funding Information: Dr. Daumer serves on the scientific advisory board for EPOSA study; has received funding for travel from ECTRIMS; serves on the editorial board of MedNous; is author on patents re: Apparatus for measuring activity (Trium Analysis Online GmbH), Method and device for detecting a movement pattern (Trium Analysis Online GmbH), Device and method to measure the activity of a person, Device and method to determine the fetal heart rate from ultrasound signals, Method and device for detecting drifts, jumps and/or outliers of measurement values, Device and method to determine the global alarm state of a patient monitoring system, Method of communication of units in a patient monitoring system, Method and device for detecting drifts, jumps and/or outliers of measurement values, and System and method for patient monitoring; serves as Managing Director of and holds stock/stock options in Trium Analysis Online GmbH (50\% effort); serves as a consultant for University of Oxford, Imperial College London, University of Southampton, Charite, Berlin, University of Vienna, Greencoat Ltd, Biopartners, Biogen Idec, Bayer Schering Pharma, Roche, and Novartis; and receives/has received research support from the EU-FP7, BMBF, BWiMi, and Hertie Foundation. Dr. Weinshenker serves on data safety monitoring boards for Novartis and Biogen Idec; serves on the editorial boards of the Canadian Journal of Neurological Sciences, the Turkish Journal of Neurology, and Multiple Sclerosis; has received research support from the Guthy-Jackson Charitable Foundation; and receives license royalties from RSR Ltd. for a patent re: Aquaporin-4 associated antibodies for diagnosis of neuromyelitis optica. Dr. Voskuhl is an inventor on a UCLA patent for estriol treatment in MS, for which she has received royalties; serves as a consultant for Adeona Pharmaceuticals; and has received research support from the National Multiple Sclerosis Society, the NIH (NINDS, NIAMS), the Skirball Foundation, the Conrad Hilton Foundation, and the Sherak Family Foundation.",
year = "2012",
month = mar,
day = "20",
doi = "10.1212/WNL.0b013e31824d1858",
language = "English (US)",
volume = "78",
pages = "846--848",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "12",
}